Clinical Trial Update: TMC649128HPC1002 - a Trial inGenotype 1 Hepatitis C Virus (HCV) - Infected Participants to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of TMC649128, Alone and Combined With Pegylated Interferon + Ribavirin [Phase 1]

View source ↗

Summary

Phase 1 trial to assess safety, tolerability, pharmacokinetics and antiviral activity of TMC649128 alone and with pegylated interferon plus ribavirin in genotyp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)
• TMC649128

Snippet

Sponsor: Tibotec BVBA | Conditions: Hepatitis C Virus | Phase 1 | Status: TERMINATED